小智港股覆盤 | 9月17日
今日，港股三大指數集體上漲。截止收盤，恆生指數漲1.03%，報24920點。國企指數漲1.53%，報8940點。恆生科技指數大漲3.52%，報6452點。市場約959只個股上漲，799只個股下跌。成交額突破1938.31億港幣，和昨天同期相比增長28.52%。
盤面上，生物科技板塊暴漲。百濟神州漲超20%；信達生物、科濟藥業-B、雲頂新耀-B等多股漲超8%；諾誠健華-B漲超7%。麥格裏升百濟神州(06160)目標價46%至148.07港元，維持“跑輸大市”評級；中金升雲頂新耀-B(01952.HK)目標價至85元，評級「跑贏行業」；諾誠健華-B(09969)擬發行不超過2.65億股A股於科創板上市。
互聯網醫療板塊暴漲。阿裏健康、醫脈通等多股漲超8%；醫渡科技漲超5%。高盛首予阿裏健康(00241.HK)「買入」評級，目標價17元。
CRO板塊全線走強。昭衍新藥漲超7%；維亞生物、方達控股等多股漲超6%；藥明生物、泰格醫藥等多股漲超5%。昭衍新藥(06127.HK)擬參加“2021年北京轄區上市公司投資者集體接待日”活動；泰格醫藥(03347.HK)9月16日耗資1319萬元回購8.26萬股A股。
消費信貸板塊概念走低。鼎豐集團控股跌超8%；中盈盛達融資擔保跌超6%；中國置業投資、維信金科等多股跌超5%。
石油天然氣板塊概念走低。中國煤層氣跌超17%；中廣核礦業跌超13%；中港石油、亞美能源、元亨燃氣等多股跌超9%。中廣核礦業(01164.HK)遭China General Nuclear Power Corporation減持1000萬股。
有色金屬和鋼鐵板塊概念走低。天時軟件跌超13%；西王特鋼跌超10%；鐵貨跌超8%；康利國際控股跌超7%；易大宗跌超6%。西王特鋼(01266.HK)大股東出售2.77億股，股價飆升62%創近年半高；鐵貨(01029)根據股份期權計劃行使期權合共增發300萬股。
uSMART智能寫手的信息、數據均來自媒體公開報道，智能寫手不能保證其完全準確，內容僅供參考，不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
